A Medical Device Daily
Cord Blood America (CBA; Los Angeles) reported that it has acquired the assets of CureSource (Charleston, South Carolina), a private umbilical cord blood storage company. Details of the transaction were not disclosed.
“This is our third acquisition as we continue to grow Cord Blood America into a major umbilical cord blood storage company worldwide,” said Matthew Schissler, CEO/chairman of CBA. “The CureSource transaction provides us with additional customers, and with a new territory to broaden the sales channels that the CureSource staff vigorously developed.”
CureSource, founded in 2003, is known for offering affordable service and for the careful attention it provides families storing their umbilical cords for possible future medical use.
CBA is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, the company says that cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.